Table 1.
Outcomes | Source | Independent Variables | Sources |
---|---|---|---|
TB Incidence per 100,000 | 14 | % NTP Budget for Management and Administration | 8,9,19 |
Retreatments per TB Incidence | 14 Derived | % NTP Budget for Staff | 8,9,19 |
TB Case Detection Rate (%) | 14 | % NTP Budget for First-Line Drugs | 8,9,19 |
Smear Positive TB Deaths per Smear Positive TB Incidence | 14 Derived | % NTP Budget for Laboratory Equipment and Supplies | 8,9,19 |
Relapse TB cases per TB Incidence | 14 Derived | %NTP Budget for MDR-TB | 8,9,19 |
Defaulted Retreatment TB Cases per Retreatment TB Cases | 14 Derived | % NTP Budget for TB-HIV | 8,9,19 |
Incidence of Extrapulmonary TB per TB Incidence | 14 Derived | % NTP Budget for ACSM/CTBC | 8,9,19 |
TB Prevalence per 100,000 | 14 | % NTP Budget for DOT Program | 8,9,19 |
TB Notification per TB Incidence | 14 Derived | NTP Budget/Capita | 8,9,14,19 Derived |
Drug Susceptibility Tests per TB Incidence | 14 Derived | NTP Budget/GDP | 8,9,14,19 Derived |
HIV Testing Among TB Patients per TB Incidence | 14 Derived | Percent of the Population Covered by DOT Program | 3 |
TB Mortality per 100,000 | 14 | - | - |
Covariates from Dye et al. [10] | Source | ||
Human Development Index | 15 | ||
Corruption Perception Index | 16 | ||
GDP/Capita | 17 | ||
% of Population With Income <$2/day | 17 | ||
Percentage of Foreign-Born TB Patients | 17 | ||
Diabetes Prevalence age 20-79 | 17 | ||
% of Population Undernourished | 17 | ||
% of Female Population That Smokes | 17 | ||
HIV Prevalence | 14 | ||
HIV Prevalence in TB Patients | 14 | ||
% of Population With Improved Water Source (Urban) | 17 | ||
% of Population With Improved Water Source (Rural) | 17 | ||
% of Population With Improved Sanitation (Urban) | 17 | ||
% of Population With Improved Sanitation (Rural) | 17 | ||
% of Population Using Solid Fuel | 18 | ||
Total Health Expenditure/Capita | 17 | ||
Government Health Expenditure /Capita | 17 | ||
Total Health Expenditure/GDP | 17 | ||
Physicians/100,000 | 17 | ||
Under-5 Mortalities | 17 | ||
Annual Change in Under-5 Mortalities | 10 | ||
Expenditure on TB Control/Capita | 8,9,19 | ||
New Smear Positive Cases Detected | 14 |
Afghanistan, Bangladesh, Brazil, Cambodia, China, D.R. Congo, Ethiopia, India, Indonesia, Kenya, Mozambique, Myanmar, Nigeria, Pakistan, Philippines, Russia, South Africa, Tanzania, Thailand, Uganda, Vietnam, Zimbabwe